Strabismus Global Clinical Trials Review, H2, 2018

GlobalData's clinical trial report, “Strabismus Global Clinical Trials Review, H2, 2018" provides an overview of Strabismus clinical trials scenario. This report provides top line data relating to the clinical trials on Strabismus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Allergan Plc

Pediatric Eye Disease Investigator Group

Herantis Pharma Plc

GlaxoSmithKline Plc

Eidactics

Allergan Plc

Pediatric Eye Disease Investigator Group

Herantis Pharma Plc

GlaxoSmithKline Plc

Eidactics

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region ...

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of Strabismus to Ophthalmology Clinical Trials 16

Clinical Trials by Phase in G7 Countries 17

Clinical Trials in G7 Countries by Trial Status 18

Clinical Trials by E7 Countries: Proportion of Strabismus to Ophthalmology Clinical Trials 19

Clinical Trials by Phase in E7 Countries 20

Clinical Trials in E7 Countries by Trial Status 21

Clinical Trials by Phase 22

In Progress Trials by Phase 23

Clinical Trials by Trial Status 24

Clinical Trials by End Point Status 26

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Strabismus Therapeutics Clinical Trials 30

Prominent Drugs 31

Clinical Trial Profile Snapshots 32

Appendix 50

Abbreviations 50

Definitions 50

Research Methodology 51

Secondary Research 51

About GlobalData 52

Contact Us 52

Source 53

List of Tables

Strabismus Therapeutics, Global, Clinical Trials by Region, 2018* 7

Strabismus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Strabismus Therapeutics, Global, ...

Strabismus Therapeutics, Global, Clinical Trials by Region, 2018* 7

Strabismus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Strabismus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Strabismus Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 11

Strabismus Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12

Strabismus Therapeutics Clinical Trials, North America, Top Countries, 2018* 13

Strabismus Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14

Strabismus Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15

Proportion of Strabismus to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 16

Strabismus Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17

Strabismus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18

Proportion of Strabismus to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 19

Strabismus Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20

Strabismus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21

Strabismus Therapeutics, Global, Clinical Trials by Phase, 2018* 22

Strabismus Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 23

Strabismus Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24

Strabismus Therapeutics Clinical Trials, Global, by End Point Status, 2018* 26

Strabismus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 27

Strabismus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 28

Strabismus Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 29

Strabismus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 30

Strabismus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 31

List of Figures

Strabismus Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Strabismus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Strabismus Therapeutics, ...

Strabismus Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Strabismus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Strabismus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Strabismus Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 11

Strabismus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12

Strabismus Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13

Strabismus Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14

Proportion of Strabismus to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 16

Strabismus Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17

Strabismus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18

Proportion of Strabismus to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 19

Strabismus Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20

Strabismus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21

Strabismus Therapeutics, Global, Clinical Trials by Phase (%), 2018* 22

Strabismus Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 23

Strabismus Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24

Strabismus Therapeutics Clinical Trials, Global, by End Point Status, 2018* 26

Strabismus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 27

Strabismus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 28

Strabismus Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 29

Strabismus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 30

Strabismus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 31

GlobalData Methodology 51

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports